Clinical Commercial Payer Forum Podcasts

A Five step Market Access programme with Mathias Flume & Omar Ali

First Name		*
Last Name		*
Email Address		*
Job Title		*
Company Name		*
Telephone		*
Country	< Please select > Afghanistan Albania Algeria American Samoa Andorra Angola Antigua Argentina Armenia Aruba Ascension Island Australia Australian Ext. Terr. Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil British Virgin Islands Brunei Brunei Darussalm Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Caribbean Nations Cayman Islands Central African Republic Chad Chile China Colombia Comoros and Mayotte Congo Congo-DR Cook Islands Costa Rica Cote d'Ivory Country Croatia Cuba Cyprus Czech Republic Denmark Diego Garcia Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Antilles French Guiana Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Grenada/Carricou Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kiribati Republic Estado de México Korea Korea The Netherlands Isle of Man Republic of Kazakhstan Korea (North) Korea (South) Kuwait Kyrgyz Republic Kyrgyzstan Lao PDR Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue North Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Rep. of Republic of Macedonia Reunion Romania Russia Rwanda Samoa San Marino Sao Tome Sao Tome and Principe Saudi Arabia Senegal Serbia Serbia and Montenegro Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka St. Helena St. Kitts St. Lucia St. Pierre & Miquelon St. Vincent Sudan Suriname Swaziland Sweden Switzerland Syria Syrian Arab Republic Tahiti Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu U.A.E. Uganda Ukraine United Arab Emirates United Kingdom Uruguay USA Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Wallis and Futuna Western Samoa Yemen Yemen Arab Republic Zaire Zambia Zimbabwe Liechtenstein	*

1. On the surface the German Market Access system appears centralised – it is really? The regional variation in prescription data indicates otherwise…
2. Prescriptions with a premium price – the good the bad and the ugly.
3. Why clear benefit for the patient still comes top of the GBA checklist.
4. The quality of life endpoint – ‘If the car doesn’t drive faster you don’t need a better seat’!

Also an exclusive update!

1. Value Based Pricing – the new road map, from the NHS with Omar Ali.

To download all event podcasts please fill in the adjacent form.

 The combination of pharma and payer insight at the event is unrivaled. These are people excited to make a real difference, an innovative and exciting group it is a must attend event for me and my regional heads. 

Bruno Osterwalder, Global Head of Early Development Oncology, Merck Serono